Adipose tissue mass and location affect circulating adiponectin levels
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Aims/hypothesisPlasma levels of adiponectin are inversely associated with body mass. We hypothesised that adipose tissue distribution and body composition influences adiponectin levels.MethodsWe assessed plasma adiponectin concentrations and dual-energy X-ray absorptiometry (DEXA) measurements of body composition among 2,820 participants from the Dallas Heart Study.ResultsAmong both women and men, adiponectin levels were higher in whites than in either Hispanics or African-Americans (for women: median 9.99 μg/ml [25th,75th percentile 7.11, 13.77] vs 7.56 μg/ml [5.05, 9.98] vs 6.39 μg/ml [4.37, 9.41], respectively, p < 0.0001; for men: 6.43 μg/ml [4.66, 9.19] vs 5.55 μg/ml [3.64, 7.50] vs 5.03 μg/ml [3.39, 7.28], p < 0.0001). In univariate analysis, each individual component of body mass was inversely associated with adiponectin. After multivariate analysis, adiponectin levels were found to be positively associated with lower extremity fat, whether expressed in absolute mass (for women: β = 0.055, p < 0.0001; for men: β = 0.061, p < 0.0001), or as a relative proportion (for women: β = 0.035, p < 0.0001; for men: β = 0.034, p < 0.0001). This association was consistent across ethnicities. Conversely, adiponectin was negatively correlated with truncal fat, both in absolute (for women: β = −0.039, p < 0.0001; for men: β = −0.044, p < 0.0001) and relative terms (for women: β = −0.027, p < 0.0001; for men β = −0.033, p < 0.0001). At the extreme of body mass, higher degrees of lower extremity and truncal adiposity were associated with higher levels of adiponectin.Conclusions/interpretationThese data suggest that the location of adipose depots differentially influences circulating adiponectin concentrations—a finding observed across ethnicity and sex. Gross measures of body mass alone do not adequately account for adiponectin levels. This supports a role of adiponectin as a mediator of the positive effects of lower extremity adiposity on improvements in insulin sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationCnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · cited 1×
“Indeed, there is a significant first-pass extraction of IL-6 of as much as 50% across the splanchnic bed [30].”
Self-citationObesity-associated improvements in metabolic profile through expansion of adipose tissue
Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31021 · Cited by 1,310 · cited 2×
“Furthermore, overproduction of adiponectin appears to mimic the effects seen with chronic peroxisome proliferator-activated receptor (PPAR)-γ agonist treatments and triggers improvements in lipid metabolism through expression of a number of genes involved with lipid metabolism and adipogenesis, including PPAR-γ2 (also…”
Self-citationAdiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991 · cited 1×
“Cross-sectional studies in humans have consistently shown a relationship between higher adiponectin levels and lower risk for the development of type 2 diabetes [7] and its associated comorbidities, such as atherosclerosis [8–10] and hepatic steatosis [11, 12].”
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Self-citationCombs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1068 · Cited by 545 · cited 1×
“Furthermore, overproduction of adiponectin appears to mimic the effects seen with chronic peroxisome proliferator-activated receptor (PPAR)-γ agonist treatments and triggers improvements in lipid metabolism through expression of a number of genes involved with lipid metabolism and adipogenesis, including PPAR-γ2 (also…”
Self-citationInfluence of body fat content and distribution on variation in metabolic risk
Vega, G. L., Adams-Huet, B., Peshock, R., Willett, D., Shah, B., & Grundy, S. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0814 · Cited by 312 · cited 2×
“Previous data from the Dallas Heart Study showed an inverse relationship between the proportion of fat in the lower extremities and markers of the metabolic syndrome, including HOMA-insulin resistance, triacylglycerol/HDL-cholesterol ratio, C-reactive protein, and systolic blood pressure [14, 20, 21].”
Self-citationInflammation and Race and Gender Differences in Computerized Tomography‐measured Adipose Depots
Beasley, L. E., Koster, A., Newman, A. B., Javaid, M. K., Ferrucci, L., Kritchevsky, S. B., Kuller, L. H., Pahor, M., Schaap, L. A., Visser, M., et al. (2009) · Obesity · doi:10.1038/oby.2008.627 · Cited by 234
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
What we talk about when we talk about fat
Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373
Targeting adipose tissue in the treatment of obesity-associated diabetes
Kusminski, C. M., Bickel, P. E., & Scherer, P. E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.75 · Cited by 678
Self-citationDysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults
Neeland, I. J., Turer, A. T., Ayers, C. R., Powell-Wiley, T. M., Vega, G. L., Farzaneh-Far, R., Grundy, S. M., Khera, A., McGuire, D. K., & de Lemos, J. A. (2012) · JAMA · doi:10.1001/2012.jama.11132 · Cited by 648
Self-citationAdiponectin: mechanistic insights and clinical implications
Turer, A. T., & Scherer, P. E. (2012) · Diabetologia · doi:10.1007/s00125-012-2598-x · Cited by 632
Self-citation
Metadata
- Authors
- Turer, A. T., Khera, A., Ayers, C. R., Turer, C. B., Grundy, S. M., Vega, G. L., & Scherer, P. E.
- Venue
- Diabetologia
- Published
- 2011-07-22
- Volume
- 54
- Issue
- 10
- Pages
- 2515-2524
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2151852249
- Cited by
- 125
- References
- 11
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adipose tissue mass and location affect circulating adiponectin levels. https://app.cochat.ai/papers/10.1007/s00125-011-2252-z
- The paper
- Turer, A. T., Khera, A., Ayers, C. R., Turer, C. B., Grundy, S. M., Vega, G. L., & Scherer, P. E. (2011). Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia. https://doi.org/10.1007/s00125-011-2252-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.